These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38441348)

  • 1. Progress in research on the role played by myeloid-derived suppressor cells in liver diseases.
    Sun Q; Dai H; Wang S; Chen Y; Shi H
    Scand J Immunol; 2023 Oct; 98(4):e13312. PubMed ID: 38441348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more.
    Shibata M; Nanno K; Yoshimori D; Nakajima T; Takada M; Yazawa T; Mimura K; Inoue N; Watanabe T; Tachibana K; Muto S; Momma T; Suzuki Y; Kono K; Endo S; Takenoshita S
    Oncotarget; 2022 Nov; 13():1273-1285. PubMed ID: 36395389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases.
    Ma H; Xia CQ
    Mediators Inflamm; 2018; 2018():4316584. PubMed ID: 30670926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.
    Li M; Zhu D; Wang T; Xia X; Tian J; Wang S
    Front Immunol; 2018; 9():2849. PubMed ID: 30564242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
    Sehgal R; Kaur N; Ramakrishna G; Trehanpati N
    Dig Dis; 2022; 40(3):301-312. PubMed ID: 34157708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.
    Zhang J; Hodges A; Chen SH; Pan PY
    Cell Immunol; 2021 Apr; 362():104300. PubMed ID: 33582607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Function and Therapeutic Implications of TNF Signaling in MDSCs.
    Yu K; Yu C; Jiao L; Miao K; Ni L; Rao X; Zhou L; Zhao C
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cell: A crucial player in autoimmune diseases.
    Xu D; Li C; Xu Y; Huang M; Cui D; Xie J
    Front Immunol; 2022; 13():1021612. PubMed ID: 36569895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Metabolism in Tumor-Associated Myeloid-Derived Suppressor Cells.
    Liu W; Song H; Li X; Ren D; Ding S; Li Y
    Adv Exp Med Biol; 2021; 1316():103-115. PubMed ID: 33740246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy.
    Krishnamoorthy M; Gerhardt L; Maleki Vareki S
    Cells; 2021 May; 10(5):. PubMed ID: 34065010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside.
    Zhao F; Gong W; Song J; Shen Z; Cui D
    Front Immunol; 2022; 13():1021634. PubMed ID: 36189262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
    Salminen A; Kaarniranta K; Kauppinen A
    Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation.
    van Geffen C; Heiss C; Deißler A; Kolahian S
    Front Immunol; 2022; 13():933847. PubMed ID: 36110844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of myeloid-derived immunosuppressive cells in cardiovascular disease.
    Li Q; Mei A; Qian H; Min X; Yang H; Zhong J; Li C; Xu H; Chen J
    Int Immunopharmacol; 2023 Apr; 117():109955. PubMed ID: 36878043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
    Rajabinejad M; Salari F; Gorgin Karaji A; Rezaiemanesh A
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4149-4158. PubMed ID: 31698956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.
    Suszczyk D; Skiba W; Jakubowicz-Gil J; Kotarski J; Wertel I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.
    Zhang W; Li J; Qi G; Tu G; Yang C; Xu M
    J Transl Med; 2018 Jan; 16(1):19. PubMed ID: 29378596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of myeloid derived suppressor cells in musculoskeletal disorders.
    Ren Y; Bäcker H; Müller M; Kienzle A
    Front Immunol; 2023; 14():1139683. PubMed ID: 36936946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.